Product Document Searching Made Easy by 2D Code! | TCI Chemistry News July 2026 | [Product Highlights] Reagent for the Introduction of... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 15307-79-6 | Product Number: D2508
Diclofenac Sodium Salt
×
Purity: >98.0%(HPLC)(qNMR)
Synonyms:
- 2-(2,6-Dichloroanilino)phenylacetic Acid Sodium Salt
- Sodium 2-(2,6-Dichloroanilino)phenylacetate
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 25G |
$96.00
|
34 | 11 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | D2508 |
Purity / Analysis Method 
|
>98.0%(HPLC)(qNMR) |
| Molecular Formula / Molecular Weight | C__1__4H__1__0Cl__2NNaO__2 = 318.13 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 15307-79-6 |
| Related CAS RN
|
15307-86-5 |
| Reaxys Registry Number | 3581138 |
| PubChem Substance ID | 87568933 |
| Merck Index (14) | 3081 |
| MDL Number | MFCD00082251 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(qNMR) | min. 98.0 % |
| Solubility in Methanol | almost transparency |
| NMR | confirm to structure |
Properties (reference)
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
| RTECS# | AG6330000 |
Transport Information:
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| H.S.code* | 2922.49-000 |
Application
DNA aptamer research
Reference
- ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid
Application
Diclofenac Sodium Salt: A Non-Selective Non-Steroidal Anti-Inflammatory Drug (NSAID)
Diclofenac sodium salt is a sodium salt of diclofenac [D3748] which is a non-steroidal anti-inflammatory drug (NSAID) with strong analgesic activity. It is a non-selective cyclooxygenase (COX) inhibitor. COX directs the formation of several key mediators of inflammation called prostaglandins. Thus, diclofenac sodium salt reduces the synthesis of prostaglandins. Diclofenac sodium salt is often used as a delayed-release dosage form of diclofenac. In addition, diclofenac sodium salt has been reportedly found to possess antibacterial activity. (The product is for research purpose only.)
References
- Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy (a review)
- On the use of the Weibull function for the discernment of drug release mechanisms
- Formulation optimization of controlled release diclofenac sodium microspheres using factorial design
- Preparation and characterization of a novel pH-sensitive chitosan-g-poly (acrylic acid)/attapulgite/sodium alginate composite hydrogel bead for controlled release of diclofenac sodium
- The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target (a review)
- Diclofenac sodium (a review on the preparation, physical properties, stability, toxicity, and analytical methods for detection of diclofenac sodium)
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Enter TCI Product Number
Enter KISHIDA Product Number
4-5 alphanumeric characters before the hyphen
7 alphanumeric characters
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
• The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
• Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
• If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
• Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
The requested analytical chart is not available. Sorry for the inconvenience.